• SENSEX 77,414.92
    -191.51 (--0.25%)
  • BANKNIFTY 51,564.85
    -11.00 (--0.02%)
  • Hind.Aeronautics
    4,294.00 5,675.00(%)
  • Zomato Ltd
    200.50 146.85(%)
  • Aster DM Health.
    504.00 558.30(%)
  • Reliance Industr
    1,269.05 1,156.00(%)
  • Tata Motors
    684.90 1,179.05(%)
  • Jio Financial
    232.25 394.70(%)
  • Mazagon Dock
    2,635.55 920.48(%)
  • Vodafone Idea
    6.77 6.60(%)
  • HDFC Bank
    1,836.40 1,880.00(%)
  • Suzlon Energy
    56.40 37.95(%)
  • M & M
    2,635.10 1,872.45(%)
  • IDFC First Bank
    54.63 52.60(%)
  • Dixon Technolog.
    13,019.00 7,100.05(%)
  • I R F C
    123.65 108.05(%)
  • Bharat Electron
    306.50 340.35(%)
  • Adani Energy Sol
    863.60 588.25(%)
  • Asian Paints
    2,322.35 2,125.00(%)
  • Reliance Power
    44.75 54.25(%)
  • Hindustan Copper
    218.75 195.35(%)
  • IndusInd Bank
    643.70 605.40(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Samrat Pharmachem Ltd Pharmaceuticals - Indian - Bulk Drugs

  • Indian Private
  • BSE Code : 4878.0
  • ISIN : INE103E01016
312.75 -5 (-1.50%)
  • As on 31 Mar 2025 (EOD)

  • Today’s Low

    306.05

  • Today’s High

    322.00

  • Open

    316.00

  • Perv Close

    317.50

  • 52W Low

    306.05

  • 52W High

    646.00

Key Indicators

  • P/E(TTM)

    10.85

  • Mar.Cap (₹Cr.)

    96.64

  • Div & Yield %

    0.32

  • Book Value(₹)

    224.64

  • Debt-Equity Ratio

    -1.50

  • AGM Date

    28-Mar-2025

  • EPS

    28.82

  • P/E Ratio

    10.85

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    96.64

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    3.09

  • BV (₹)

    224.60

  • Sales( ₹ in Cr.)

    281.58

  • NP (in Cr.)

    2.15

  • NP Var(%)

    -87.0

  • Div%

    10.0

  • CPS (₹)

    9.00

  • EPS (₹)

    6.90

  • Traded Value (₹ in Lakhs)

    96.64

  • 52 Week High

    646.00

  • 52 Week Low

    306.05

  • Price BSE

    313.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    96.64

  • P/C Ratio

    34.60

  • P/E Ratio

    45.10

  • Price Vs.BV

    6.90

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019
Sales Turnover 281.58 310.65 221.75 204.37 157.12 125.36
Excise Duty 281.58 310.65 221.75 204.33 157.07 125.33
Net Sales 281.58 310.65 221.75 204.37 157.12 125.36
Other Income 1.38 0.48 0.63 0.46 0.57 0.46
Stock Adjustments 0.00 0.00 0.00 0.00 0.00 0.00
Total Income 282.97 311.12 222.38 179.48 138.02 111.59
EXPENDITURE :
Raw Materials 281.58 310.65 221.75 204.33 157.07 125.33
Power & Fuel Cost 281.58 310.65 221.75 204.33 157.07 125.33
Employee Cost 2.22 1.88 1.77 1.50 1.44 1.38
Other Manufacturing Expenses 0.78 0.76 0.55 0.46 0.12 0.05
Selling & Administrative Expenses 2.41 2.46 1.72 1.45 1.46 1.72
Miscellaneous Expenses 0.78 0.76 0.55 0.46 0.12 0.05
Less : Pre-operative Expenses Capitalised :
Total Expenditure 280.45 288.59 198.78 172.12 132.23 109.44
Operating Profit 3.38 3.76 3.57 2.69 2.19 2.18
Interest 0.69 1.23 0.67 1.28 0.98 1.06
Gross Profit 2.52 22.53 23.60 7.34 5.78 2.16
Depreciation 0.65 0.64 0.59 0.49 0.43 0.42
Profit Before Tax 2.52 22.53 23.60 7.34 5.78 2.16
Tax 0.20 6.16 6.38 1.72 1.72 0.61
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.08 -0.21 0.03 0.29 -0.18 0.01
Reported Net Profit 2.16 16.63 17.18 5.33 4.24 1.54
Extraordinary Items 2.52 22.53 23.60 7.34 5.78 2.16
Adjusted Net Profit 2.16 16.63 17.18 5.33 4.24 1.54
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward 0.00 0.00 0.00 0.00 0.00 0.00
Statutory Appropriations 0.31 0.31 0.31 0.00 0.00 0.00
P & L Balance carried down 2.16 16.63 17.18 5.33 4.24 1.54
Dividend - - - - - -
Preference Dividend - - - - - -
Equity Dividend (%) 10.00 10.00 10.00 0.00 0.00 0.00
Dividend Per Share(Rs) 1.00 1.00 1.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 7.00 53.83 55.62 17.26 13.71 4.97
Book Value 0.31 0.31 0.31 0.00 0.00 0.00
Book Value(Adj)-Unit Curr 0.31 0.31 0.31 0.00 0.00 0.00

Shareholding Pattern

  • Promoter Group

    49.09%

  • Public Share Holding

    50.91%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 1,516,767 49.09 1,516,767 10
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 1,516,767 49.09 1,516,767 10
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 100,000 3.24 0 1
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 100,000 3.24 0 1
2] Non Institution
Bodies Corporate 81,047 2.62 79,547 38
Clearing Members 96 0.00 96 1
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 60,615 1.96 50,215 135
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 34,053 1.10 34,053 101
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 173,747 5.62 173,747 3
Individuals holding nominal share capital up to Rs. 1 lakh 1,122,303 36.32 922,303 6,551
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 572 0.02 572 2
Sub Total 1,472,933 47.67 1,261,033 6,833
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 3,089,700 100.00 2,777,800 6,844

Company Background

Samrat Pharmachem LtdPharmaceuticals - Indian - Bulk Drugs

  • Samrat Pharmachem Ltd
  • BSE Code : 4878.0
  • ISIN : INE103E01016

  • Incorporation Year

    1992

  • Registered Office

    Plot No A2/3445
    GIDC Phase IV, Ankleshwar,
    Gujarat-393002

  • Telephone

    91-2646-220774

  • FAX

    91-2646-251291

  • Chairman

    Lalit Mehta

  • Managing Director

    Lalit Mehta

  • Company Secretary

    Nishant Kankaria

  • Auditor

    Shah & Savla LLP

  • Face Value

    10

  • Listing

    BSE

  • Registrar

    Link Intime India Pvt Ltd
    C-13 Pannalal Silk,
    Mills Cmpd LBS Marg,Bhandup West
    Mumbai - Mumbai - 400 078

Samrat Pharmachem Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Samrat Pharma 312.75 282.97 281.58 10.85 4.14
Abbott India 30,730.65 6,097.18 5,848.91 48.94 44.71
Astrazeneca Phar 8,606.35 1,330.33 1,295.53 221.87 33.26
P & G Health Ltd 5,142.30 1,166.89 1,151.26 36.08 39.76
Glaxosmi. Pharma 2,877.30 3,530.73 3,407.25 57.21 44.44
Cipla 1,441.70 17,645.00 16,574.34 24.72 20.10
Amrutanjan Healt 644.85 437.58 421.23 37.80 20.84
Guj. Themis Bio. 281.50 174.19 169.82 58.28 44.82
Fermenta Biotec. 273.55 315.24 307.09 25.93 4.10
Bliss GVS Pharma 117.55 638.96 605.46 26.90 11.19
Ambalal Sarabhai 35.05 11.70 3.81 14.98 1.92